count mdlz quarterli result repres eighth nine larg cap consum
stapl compani beat organ sale growth expect nine best
ep forecast still earli packag food earn cycl realli stand
us regard food peer proactiv reinvest mode
pivot growth one alreadi see result invest spend
see well ahead time-frame envis mani other believ
much compani recent spend opportun even expect benefit
expect solid organ sale gain quarter yoy mdlz result last
night far surpass expect organ revenu came yoy includ
yoy emerg market growth yoy ex argentina result still earli
year would fulli expect full year consensu organ sale growth estim rise
match yoy growth forecast could still well end conserv
high end compani current yoy target
mention march note thing come three organ
acceler key investor begin fulli appreci sustain
top line growth line mdlz long term algorithm yoy believ share
could still re-rat closer multi-national peer cl pg ko
admittedli deliv closer yoy averag organ growth current trade
averag price-to-earnings -- three turn ahead rais
target price base price-to-earnings multipl
unchang full year ep estim updat target price conserv assum
mdlz price-to-earnings multipl close multipl gap aforement peer
organ revenu growth broad base across geographi notabl balanc
price volum clear us compani effort better balanc gross
margin profit dollar take hold fact even though benefit price
acceler sequenti yoy volum acceler believ augur
well continu top line momentum progress
quarterli annual ep usd
rais usd
return equiti ttm
link barclay live interact chart
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
overweight continu recommend
share given long-term potenti compani
deliv peer-lead sale earn growth
compani strateg option rel
valuat believ upsid
assum robust top-lin earn growth
along benefit fx see upsid
ep potenti appli price-to-earnings
multipl impli upsid valu
assum challeng organ sale backdrop
less favor fx less meaning margin
expans see potenti downsid
ep estim appli price-to-earnings multipl
impli downsid valu
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
stock
said continu look ep high end mdlz yoy
constant fx guidanc rang though includ fx headwind vs
previous result give us confid increment pressur
overcom current level busi momentum notabl model organ growth
slow sequenti somewhat primarili due likelihood magnitud price
argentina come though still expect organ sale growth yoy
full year high end mdlz full year yoy guidanc rang --
frankli could conserv still view mind move price
target predic price-to-earnings multipl ep estim
premium group -- believ merit given mdlz
build top-lin momentum advantag categori credibl playbook prior
price target predic price-to-earnings multipl ep estim
interestingli report modest organ growth yoy key
north america segment consum take-away overal around robust
yoy explain disconnect due three thing slowdown gum candi
quarter particularli candi driven later hall hit hard due
good cold season competit pressur vick retail lower
stock level littl bit slower growth non-measur channel
import us fact consumpt remain solid lead indic
acceler recent period end yoy
yoy recent period though would note like
benefit time compani clearli still work
suppli chain issu higher cost improv servic level come
clear us start get arm around key north america region
busi momentum move right direct though would necessarili
expect linear fashion
alreadi mention organ sale growth fairli broad base across geographi
particular continu see momentum emerg market post growth
yoy yoy exclud argentina notabl deliv strong result
india china southeast asia russia mexico africa specif india
deliv dd yoy growth russia grew dd yoy well china southeast asia
mexico grew msd yoy africa post posit growth well meanwhil brazil
return growth quarter expect see steadi improv
region throughout year deliv solid perform develop
market yoy includ good growth europ germani uk particular
steadi improv north america
andrew lazar herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
